Ninjin'yoeito ameliorates skeletal muscle complications in COPD model mice by upregulating peroxisome proliferator-activated receptor γ coactivator-1α expression
A Miyamoto, K Asai, H Kadotani… - … Journal of Chronic …, 2020 - Taylor & Francis
Purpose Sarcopenia, the loss of skeletal muscle mass and strength, is a common systemic
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α …
A Miyamoto, K Asai, H Kadotani… - … Journal of Chronic …, 2020 - dovepress.com
Purpose: Sarcopenia, the loss of skeletal muscle mass and strength, is a common systemic
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
[PDF][PDF] Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α …
A Miyamoto, K Asai, H Kadotani… - … Journal of Chronic …, 2020 - scienceopen.com
Purpose: Sarcopenia, the loss of skeletal muscle mass and strength, is a common systemic
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor [gamma] Coactivator-1 …
A Miyamoto, K Asai, H Kadotani, N Maruyama… - International Journal of …, 2020 - go.gale.com
Purpose: Sarcopenia, the loss of skeletal muscle mass and strength, is a common systemic
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
[PDF][PDF] Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α …
A Miyamoto, K Asai, H Kadotani… - … Journal of Chronic … - dlisv03.media.osaka-cu.ac.jp
Purpose: Sarcopenia, the loss of skeletal muscle mass and strength, is a common systemic
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
Ninjinâ yoeito ameliorates skeletal muscle complications in copd model mice by upregulating peroxisome proliferator-activated receptor γ coactivator-1αexpression
A Miyamoto, K Asai, H Kadotani… - International Journal of …, 2020 - hero.epa.gov
Purpose: Sarcopenia, the loss of skeletal muscle mass and strength, is a common systemic
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α …
A Miyamoto, K Asai, H Kadotani… - … journal of chronic …, 2020 - pubmed.ncbi.nlm.nih.gov
Purpose Sarcopenia, the loss of skeletal muscle mass and strength, is a common systemic
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
[HTML][HTML] Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α …
A Miyamoto, K Asai, H Kadotani… - … Journal of Chronic …, 2020 - ncbi.nlm.nih.gov
Purpose Sarcopenia, the loss of skeletal muscle mass and strength, is a common systemic
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
[PDF][PDF] Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α …
A Miyamoto, K Asai, H Kadotani… - … Journal of Chronic …, 2020 - pdfs.semanticscholar.org
Purpose: Sarcopenia, the loss of skeletal muscle mass and strength, is a common systemic
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α …
A Miyamoto, K Asai, H Kadotani… - … Journal of Chronic …, 2020 - europepmc.org
Purpose Sarcopenia, the loss of skeletal muscle mass and strength, is a common systemic
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …
consequence of chronic obstructive pulmonary disease (COPD) and is correlated with …